NCT00539851
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus
Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.
1,833 public trials
165 recruiting studies
Diabetes Mellitus trial results
Completed
Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes
NCT00348374
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +4 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Malvern, Arkansas, United States
NCT00108927
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, +7 more
- Locations
-
- Dept of Family Medicine and Community Health, University of Minnesota Medical School Minneapolis, Minnesota, United States
NCT01074762
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +4 more
- Locations
-
- The Research Unit for General Practice in Copenhagen, Centre for Health and Community, Øster Farimagsgade 5 Copenhagen, Denmark
NCT00642174
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +10 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Worcester, Massachusetts, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States
Completed
Psychosocial Treatment Intervention in Persons Newly Diagnosed With Rheumatoid Arthritis or Diabetes
NCT01066130
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
- Locations
-
- Center for Family and Community Medicine Huddinge, Sweden
- Karolinska University Hospital Solna Stockholm, Sweden
NCT00359801
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Pfizer Investigational Site Bay Minette, Alabama, United States
- Pfizer Investigational Site Fairhope, Alabama, United States
- Pfizer Investigational Site Graysville, Alabama, United States
- Pfizer Investigational Site Pell City, Alabama, United States
NCT01060917
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Profil Institut für Stoffwechselforschung GmbH Neuss, Germany
NCT01058733
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Seoul St. Mary's Hospital Seoul, South Korea
NCT01058577
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +2 more
- Locations
-
- Profil Institut für Stoffwechselforschung GmbH Neuss, Germany